FDA tries to reassure public on safety of COVID-19 vaccine
FDA Commissioner Stephen Hahn denied Saturday that the White House had threatened his job if the agency didn’t move quickly on the vaccine.
FDA
Articles
FDA authorizes first COVID-19 vaccine in bid to end surging pandemic
The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
FDA allows first rapid COVID-19 test that gives results at home
The announcement by the Food and Drug Administration represents an important step in U.S. efforts to expand testing options for COVID-19. However, the test will require a prescription, likely limiting its initial use.
White House nixes tougher FDA guidelines on vaccine approval
FDA Commissioner Stephen Hahn has pledged that career scientists, not politicians, will decide whether any coronavirus vaccine meets clearly stated standards that it works and is safe.
FDA says at least 75 brands of hand sanitizers may be toxic
The FDA also advises Americans to be wary of products that claim to be “FDA-approved,” as none exist, or say they provide protection for “up to 24 hours.”
Government to propose banning flavors used in e-cigarettes
President Donald Trump said Wednesday his administration will propose banning thousands of flavors used in e-cigarettes to combat a recent surge in underage vaping.
FDA warns top marijuana company for making CBD health claims
CVS Health, which started carrying CBD skin products in some states this year, plans to remove Curaleaf products from its shelves following the FDA’s warning.
Lilly’s push into pain research starting to pay off
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
Trump orders simpler path for genetically engineered food
The move comes as companies are turning to newer genetic engineering techniques that make it easier to tinker with the traits of plants and animals.
Food regulators pushing for clarity on expiration dates
By clarifying terms such as “Sell by” and “Use by,” U.S. regulators are trying to prevent people from prematurely tossing products and to reduce the mountains of food that goes to waste each year.
Ex-employees to testify exec knew drugs were dangerous
Paul Elmer, who founded Pharmakon 16 years ago and shut it down three years ago, faces charges of adulterating compounded drugs, conspiracy and obstructing a U.S. FDA investigation.
FDA chief Gottlieb steps down after nearly two years
Scott Gottlieb bucked expectations by pushing the agency to expand its authorities in several key ways, including an unprecedented effort to make cigarettes less addictive by requiring lower nicotine levels .
Senators ask FDA to update rules on CBD, hemp products
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
Americans, Canadians warned not to eat romaine lettuce
FDA Commissioner Scott Gottlieb said the FDA wanted to issue a warning about a new E. coli outbreak before people gathered for Thanksgiving meals, where the potential for exposure could increase.
FDA to crack down on menthol cigarettes, flavored vapes
The move represents a major step to further push down U.S. smoking rates, which have been falling for decades.
E-cigarettes facing new sales restrictions from FDA
New limitations will be placed on e-cigarettes, according to a senior FDA official, restricting sales of many popular fruit flavors amid what the health agency has called an epidemic of youth use.
Opioid alternative from Lilly, Pfizer shows promise in study
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
Migraine drug from Eli Lilly approved by FDA
Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.
Competitor beats Lilly to market with migraine drug approval
The competition for the multi-billion dollar migraine market is set to heat up with the FDA expected to decide on Lilly’s migraine therapy next month.
In setback for Lilly, FDA limits dosage, slaps warning on new arthritis drug
The Indianapolis-based drugmaker has been working for years to develop the much-anticipated drug, which some analysts had said might ring up $2 billion a year in sales.